chills; body aches; fever/The temp ranged between 100.6 and 101.2 F; This is a spontaneous report received from contactable reporter(s) (Nurse). The reporter is the patient.  A 59-year-old female patient (not pregnant) received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 21Oct2022 at 18:00 as dose 5 (booster), single (Lot number: GJG739) at the age of 59 years, in left arm for covid-19 immunisation. The patient's relevant medical history included: "Epstein barr" (unspecified if ongoing); "migraines" (unspecified if ongoing); "Sjogren's syndrome" (unspecified if ongoing); "cholecystectomy" (unspecified if ongoing); "right breast DCIS with lumpectomy and radiation" (unspecified if ongoing), notes: right breast DCIS with lumpectomy and radiation; "right breast DCIS with lumpectomy and radiation" (unspecified if ongoing), notes: right breast DCIS with lumpectomy and radiation; "right breast DCIS with lumpectomy and radiation" (unspecified if ongoing), notes: right breast DCIS with lumpectomy and radiation; "knee arthroplasty" (unspecified if ongoing); "discectomy L4 and bilateral spinal fusion L5/S1" (unspecified if ongoing), notes: discectomy L4 and bilateral spinal fusion L5/S1; "discectomy L4 and bilateral spinal fusion L5/S1" (unspecified if ongoing), notes: discectomy L4 and bilateral spinal fusion L5/S1; "Known allergies: penicillin" (unspecified if ongoing), notes: Known allergies: penicillin; "Known allergies: bee stings" (unspecified if ongoing), notes: Known allergies: bee stings; "Known allergies: minor latex allergy" (unspecified if ongoing), notes: Known allergies: minor latex allergy; "if covid prior vaccination: Yes" (unspecified if ongoing), notes: if covid prior vaccination: Yes; "rhinoplasty" (unspecified if ongoing). Concomitant medication(s) included: HYDROXYCHLOROQUINE; ATORVASTATIN; VIT D [VITAMIN D NOS]; CALCIUM. Vaccination history included: BNT162b2 (Dose 1, Single, Lot number: EL3247 administered on left arm), administration date: 25Feb2021, when the patient was 57-year-old, for COVID-19 Immunization; BNT162b2 (Dose 2, Single, Lot number: EL3247, administered on Left arm), administration date: 18Mar2021, when the patient was 57-year-old, for COVID-19 Immunization; BNT162b2 (Dose 3, Single, Lot number: EW0187, administered on Left arm), administration date: 15Oct2021, when the patient was 58-year-old, for COVID-19 Immunization; BNT162b2 (Dose 4, Lot number: FJ4991, administered on Left arm), administration date: 30Apr2022, when the patient was 58-year-old, for COVID-19 Immunization. The following information was reported: PAIN (non-serious) with onset 22Oct2022 at 04:00, outcome "recovered", described as "body aches"; CHILLS (non-serious) with onset 22Oct2022 at 04:00, outcome "recovered"; PYREXIA (non-serious) with onset 22Oct2022 at 04:00, outcome "recovered", described as "fever/The temp ranged between 100.6 and 101.2 F". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were taken as a result of chills, pain, pyrexia.  Additional information: The patient had covid prior to vaccination. The patient had not received any other vaccine within four weeks of vaccination. The patient was vaccinated at Pharmacy or Drug Store. 10 hours after receiving the vaccine the patient experienced chills, body aches and fever. The temp ranged between 100.6 and 101.2 F on 22Oct2022 at 04:00 AM. The patient had not undergone Covid-19 post vaccination. The patient received Tylenol as treatment medication for all the events.  No follow-up attempts are needed. No further information is expected